SCHEMBL21873554

SCHEMBL21873554

O=[P](C12CC3CC(CC(C3)C1)C2)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 5/20 0.38
GRIN3B O60391 5/20 0.38
GRIN1 Q05586 5/20 0.38
GRIN2A Q12879 5/20 0.38
GRIN2B Q13224 5/20 0.38
GRIN2C Q14957 5/20 0.38
GRIN3A Q8TCU5 5/20 0.38
LMNA P02545 2/20 0.38
SLC22A2 O15244 2/20 0.38
SLC47A1 Q96FL8 2/20 0.38
TSHR P16473 2/20 0.38
SLC22A1 O15245 1/20 0.38
NFKB1 P19838 1/20 0.38
STAT6 P42226 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
THRB P10828 2/20 0.36
POLB P06746 1/20 0.36
BLM P54132 1/20 0.36
PMP22 Q01453 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1877773 0.73 GRIN2D (0.42) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL27623041 0.69 GRIN2D (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL3842499 0.69 GRIN2D (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL2826080 0.69 GRIN2D (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL26786761 0.69 GRIN2D (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL2929198 0.69 GRIN2D (0.39) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL5333489 0.69 GRIN2D (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL26786757 0.69 GRIN2D (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL5463104 0.69 GRIN2D (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL1092580 0.69 GRIN2D (0.39) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3892611-B1 METHOD FOR PRODUCING FLUOROVINYL AMIDE COMPOUND DAIKIN IND LTD (JP) 2026-01-28 EP disclosed
US-20250214936-A1 METHOD FOR PRODUCING FLUOROVINYL AMIDE COMPOUND DAIKIN INDUSTRIES, LTD. (JP) 2025-07-03 US disclosed
US-12281075-B2 Method for producing fluorovinyl amide compound DAIKIN INDUSTRIES, LTD. (JP) 2025-04-22 US disclosed
US-11932596-B2 Fluorovinyl ether compound DAIKIN INDUSTRIES, LTD. (JP) 2024-03-19 US disclosed
EP-3643694-B1 METHOD FOR PRODUCING BUTADIENE COMPOUND DAIKIN IND LTD (JP) 2023-11-15 EP disclosed
US-20230144907-A1 METHOD FOR PRODUCING FLUOROVINYL ETHER COMPOUND DAIKIN INDUSTRIES, LTD. (JP) 2023-05-11 US disclosed
US-11560347-B2 Method for producing fluorovinyl ether compound DAIKIN INDUSTRIES, LTD. (JP) 2023-01-24 US disclosed
US-20220055990-A1 METHOD FOR PRODUCING FLUOROVINYL AMIDE COMPOUND DAIKIN INDUSTRIES, LTD. (JP) 2022-02-24 US disclosed
EP-3892611-A1 METHOD FOR PRODUCING FLUOROVINYL AMIDE COMPOUND DAIKIN INDUSTRIES, LTD. (JP) 2021-10-13 EP disclosed
US-20210284593-A1 METHOD FOR PRODUCING FLUOROVINYL ETHER COMPOUND DAIKIN INDUSTRIES, LTD. (JP) 2021-09-16 US disclosed
EP-3816146-A1 METHOD FOR PRODUCING FLUOROVINYL ETHER COMPOUND DAIKIN INDUSTRIES, LTD. (JP) 2021-05-05 EP disclosed
WO-2020116589-A1 METHOD FOR PRODUCING FLUOROVINYL AMIDE COMPOUND ダイキン工業株式会社 2020-06-11 WO disclosed
EP-3643694-A1 METHOD FOR PRODUCING BUTADIENE COMPOUND Daikin Industries, Ltd. (JP) 2020-04-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230144907-A1 METHOD FOR PRODUCING FLUOROVINYL ETHER COMPOUND RB1, AFF1, AFF2 GRIN2D 3377/4885GRIN3B 2682/4885GRIN1 2110/4885
US-11932596-B2 Fluorovinyl ether compound RB1, AFF1, AFF2 GRIN2D 3569/4885GRIN3B 2736/4885GRIN1 2374/4885
US-12281075-B2 Method for producing fluorovinyl amide compound RB1, KRAS, NRAS GRIN2D 2392/4885GRIN3B 2453/4885GRIN1 1081/4885
US-20250214936-A1 METHOD FOR PRODUCING FLUOROVINYL AMIDE COMPOUND RB1, KRAS, NRAS GRIN2D 2392/4885GRIN3B 2453/4885GRIN1 1081/4885
US-20220055990-A1 METHOD FOR PRODUCING FLUOROVINYL AMIDE COMPOUND RB1, KRAS, NRAS GRIN2D 2392/4885GRIN3B 2453/4885GRIN1 1081/4885
US-20210284593-A1 METHOD FOR PRODUCING FLUOROVINYL ETHER COMPOUND RB1, AFF1, AFF2 GRIN2D 3377/4885GRIN3B 2682/4885GRIN1 2110/4885
US-11560347-B2 Method for producing fluorovinyl ether compound ETV6, CYP2F1, CYP4F2 GRIN2D 2966/4885GRIN3B 3257/4885GRIN1 3273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.